Pleasanton, CA, le 10 Juin 2013 — Le fabricant américain CooperVision annonce le lancement de sa nouvelle lentille journalière MyDay. Fruit d’un travail de recherche qui aurait duré six ans, ce nouveau produit a été dévoilé en fin de semaine par la direction de CooperVision au cours d’un congrès de BCLA (British Contact Lens Association). Destinée aux myopes ou hypermétropes et conçue à base d’un matériau breveté surnommé « Smart Silicone », la nouvelle lentille journalière MyDay a été conçue pour offrir une perméabilité à l’oxygène encore plus élevée ainsi qu’une haute mouillabilité afin de garantir un confort de port de longue durée. « Face à l’évolution des lentilles en silicone-hydrogel, nous avons été patients dans notre approche pour développer une nouvelle lentille répondant à toutes les exigences essentielles des porteurs et de l’industrie » a souligné le vice-président de CooperVision, Dennis Murphy.
Les professionnels présents au congrès BCLA ont pu librement tester la lentille journalière MyDay et la plupart d’entre eux seraient satisfaits du résultat. Selon le laboratoire CooperVision, les essais cliniques ont également été concluants avec 9 patients sur 10 satisfaits de la qualité de vision et du confort de port obtenus. « Ce nouveau produit offre un équilibre optimal entre le confort, la perméabilité et la facilité de manipulation » a précisé Mark Harty, le dirigeant de la branche européenne de CooperVision.
Les paramètres de la lentille journalière MyDay de CooperVision :
Diamètre : 14.2 mm, rayon de courbure : 8.4 mm
Puissance : - 10.00 à + 6.00 dioptries
Rythme de port : usage unique, remplacement quotidien
Filtre UV : blocage de 75 % des UVA et 99 % des UVB
La nouvelle lentille MyDay sera commercialisée en premier lieu sur le marché européen dès septembre 2013, avant d’être disponible également aux Etats-Unis dès janvier 2014.
The translation can be found here:
Pleasanton, CA, 10 June 2013 — The American manufacturer CooperVision announced the launch of its new daily MyDay lens. Result of a research that lasted six years, this new product was unveiled this weekend by CooperVision management during a conference BCLA (British Contact Lens Association). Designed for myopia or hyperopia and designed based on a dubbed "Smart Silicone" patented material, the new MyDay daily lens has been designed to provide oxygen permeability even higher and a high wettability to ensure comfort Wearing long. "With the development of silicone hydrogel lenses, we have been patient in our approach to develop a new lens meets all the essential requirements of carriers and the industry," said the vice president of CooperVision, Dennis Murphy .
Professionals attending the BCLA conference could freely test MyDay daily lens and most of them are satisfied with the result. According to CooperVision laboratory, clinical trials have also been successful with nine out of 10 patients satisfied with the quality of vision and wearing comfort achieved. "This new product provides an optimal balance between comfort, permeability and ease of handling," said Mark Harty, the leader of the European branch of CooperVision.
The parameters of the daily MyDay CooperVision lens:
Diameter: 14.2 mm, bending radius: 8.4 mm
Power: - 10.00 + 6.00 diopters
Rhythm port: disposable, daily replacement
UV Filter: block 75% of UVA and UVB 99%
The new lens MyDay will be marketed first in the European market since September 2013, before being available in the U.S. in January 2014.
The original article in French can be found here:
About CooperVision
CooperVision, a unit of The Cooper Companies, Inc. [NYSE: COO], is one of the world’s leading manufacturers of soft contact lenses. Dedicated to continually bringing a fresh perspective to the contact lens experience for practitioners and patients, CooperVision specialises in lenses for astigmatism, presbyopia, and ocular dryness. The company routinely collaborates with eye-care professionals in the research and development of relevant products. CooperVision manufactures a full array of monthly and daily disposable contact lenses featuring advanced materials and optics. For more information, visit www.coopervision.com.
Contact lenses are medical devices and can only be prescribed and dispensed by a licensed eye care professional.
About The Cooper Companies
The Cooper Companies, Inc. (“Cooper”) is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women’s health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, CA, Cooper has over 7,500 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.